Chief Executive Officer		Executive Director		Legal Adviser and Director
	Chief Technical Officer		Chief Scientific Officer		Chief Operating Officer
	Chief Financial Officer

Chief Scientific Officer: Professor Denys Wheatley,PhD

Professor Denys Wheatley , is the pioneer in arginine depletion research and a member of the editorial board of a number of biotech jounral. He as the Professor emritus Professor of Cell Biology, University of Aberdeen, UK. We have the honour from Professor Wheatley to be our Chief Scientific Officer in 2007.

Chief Scientific Officer cum Marketing Officer (PEG Division): Dr. Stanton Kok, PhD

Dr. Stanton Kok, studied BSc and MSc at Salford University (UK). On his return to Hong Kong he gained PhD in organic chemistry at the Chinese University of Hong Kong. In 2001, he joined the Hong Kong Polytechnic University as a team leader of medicinal group under the supervision of Prof. Albert Chan. Three years later he was appointed as laboratory manager. From 2005 to 2007, he switched to Cancer Drugs Research and Development Centre as a research fellow. In addition, he was a member of PolyU Technology and Consultancy Limited (PTeC) as a scientific consultant working with various company, including, Dow chemicals, Novatis, Hong Kong Jockey Club and BCT. Dr. Stanton Kok joined BCT in Hong Kong as a CSO on March 1, 2007 with responsibility for our initial setup of GMP compliance production.